1. Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 1, monoclonal antibodies, antibody-drug conjugates and bispecific T-cell engagers. (March 2020) Authors: Paci, Angelo; Desnoyer, Aude; Delahousse, Julia; Blondel, Louis; Maritaz, Christophe; Chaput, Nathalie; Mir, Olivier; Broutin, Sophie Journal: European journal of cancer Issue: Volume 128(2020) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 2, immune checkpoint inhibitor antibodies. (March 2020) Authors: Desnoyer, Aude; Broutin, Sophie; Delahousse, Julia; Maritaz, Christophe; Blondel, Louis; Mir, Olivier; Chaput, Nathalie; Paci, Angelo Journal: European journal of cancer Issue: Volume 128(2020) Page Start: 119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Switch as maintenance to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate: week 48 results in a clinical cohort. (10th February 2017) Authors: Perrier, Marine; Charpentier, Charlotte; Peytavin, Gilles; Lê, Minh; Blondel, Louis; Visseaux, Benoit; Joly, Véronique; Pinto, Adriana; Matheron, Sophie; Yazdanpanah, Yazdan; Descamps, Diane; Landman, Roland Journal: Journal of antimicrobial chemotherapy Issue: Volume 72:Number 6(2017:Jun.) Page Start: 1745 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗